Raymond James & Associates’s AMERISAFE AMSF Stock Holding History
Bought
Maintained
Sold
Other funds holding AMSF
CIP
WHG
Raymond James & Associates's AMSF Position: Q2 2024 in Review
Raymond James & Associates sold out of AMERISAFE (AMSF) in Q2 2024, closing a stake of 50,089 shares — an estimated $2.51M sold.
Raymond James & Associates first reported a position in AMSF in Q4 2015 and held it in 20 quarters. The position peaked at $2.51M in Q1 2024. 171 funds tracked by Wall St. Rank hold AMSF as of Q2 2024.
- Raymond James & Associates reported no remaining AMERISAFE position as of Q2 2024 after selling out during the quarter.
- Raymond James & Associates sold 50,089 AMERISAFE shares in Q2 2024, an estimated $2.51M.
- Raymond James & Associates first reported a position in AMERISAFE in Q4 2015 and held it in 20 quarters.
- Raymond James & Associates's AMERISAFE position peaked at $2.51M in Q1 2024.
- 171 funds tracked by Wall St. Rank held AMERISAFE as of Q2 2024.
Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.